Zimmerer Alexander, Janz Viktor, Sobau Christian, Wassilew Georgi I, Miehlke Wolfgang
ARCUS Sportklinik Pforzheim, Germany.
Department of Orthopaedics, University Medicine Greifswald, Greifswald, Germany.
Orthop J Sports Med. 2021 Feb 25;9(2):2325967120985140. doi: 10.1177/2325967120985140. eCollection 2021 Feb.
Arthroscopic treatment of femoroacetabular impingement syndrome (FAIS) has become a common procedure. However, meaningful long-term clinical outcomes have not been defined.
To define the minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptomatic state (PASS) for the modified Harris Hip Score (mHHS) at a minimum 10-year follow-up in patients undergoing arthroscopic treatment for FAIS and identify preoperative predictors for achievement of the MCID, SCB, and PASS.
Case-control study; Level of evidence, 3.
A consecutive series of patients undergoing arthroscopic treatment for FAIS between 2007 and 2009 with a minimum 10-year follow-up was analyzed. Patient data included patient characteristics, radiographic parameters, and the pre- and postoperative mHHS and visual analog scale (VAS) for pain score. Paired tests were used to compare the patient-reported outcome measures (PROMs). The MCID was determined by calculating half of the standard deviation, and SCB and PASS were calculated by the anchor method. Correlation and logistic regression analyses were conducted to identify predictors for the achievement of the MCID, SCB, and PASS.
A total of 44 patients (27 men, 17 women) were included. The mean age and body mass index were 42.2 years (range, 16-67 years) and 22.3 kg/m (range, 16.76-29.78 kg/m), respectively. The MCID, absolute SCB, net change SCB, and PASS of the mHHS were calculated to be 19.6, 90.1, 31.5, and 84.4 points, respectively. Preoperative symptom duration was identified as an independent predictor for the achievement of meaningful clinical outcomes. The median symptom durations for patients who achieved the MCID, absolute SCB, net change SCB, and PASS were 11.7, 9.1, 9.0, and 10.8 months, respectively. The median symptom duration for patients who did not achieve the MCID, absolute SCB, net change SCB, and PASS were 15.8, 17.4, 17.3, and 18.4 months, respectively. No other statistically significant correlations were found.
The preoperative duration of symptoms was identified as an independent predictor for achievement of the MCID, SCB, and PASS. These findings can be helpful in accelerating the transition to surgical treatment of FAIS.
关节镜治疗股骨髋臼撞击综合征(FAIS)已成为一种常见手术。然而,尚未明确有意义的长期临床结果。
确定接受关节镜治疗FAIS患者至少随访10年时改良Harris髋关节评分(mHHS)的最小临床重要差异(MCID)、显著临床获益(SCB)和患者可接受症状状态(PASS),并确定实现MCID、SCB和PASS的术前预测因素。
病例对照研究;证据等级,3级。
分析2007年至2009年间连续接受关节镜治疗FAIS且至少随访10年的一系列患者。患者数据包括患者特征、影像学参数以及术前和术后的mHHS和疼痛视觉模拟量表(VAS)评分。采用配对t检验比较患者报告的结局指标(PROMs)。通过计算标准差的一半确定MCID,采用锚定法计算SCB和PASS。进行相关性和逻辑回归分析以确定实现MCID、SCB和PASS的预测因素。
共纳入44例患者(27例男性,17例女性)。平均年龄和体重指数分别为42.2岁(范围16 - 67岁)和22.3 kg/m²(范围16.76 - 29.78 kg/m²)。mHHS的MCID、绝对SCB、净变化SCB和PASS分别计算为19.6、90.1、31.5和84.4分。术前症状持续时间被确定为实现有意义临床结果的独立预测因素。实现MCID、绝对SCB、净变化SCB和PASS的患者的中位症状持续时间分别为11.7、9.1、9.0和10.8个月。未实现MCID、绝对SCB、净变化SCB和PASS的患者的中位症状持续时间分别为15.8、17.4、17.3和18.4个月。未发现其他统计学上显著的相关性。
术前症状持续时间被确定为实现MCID、SCB和PASS的独立预测因素。这些发现有助于加快向FAIS手术治疗的转变。